Long Term Outcomes in Critically Ill Haematological Patients. The Use of Intensive Care in Critically Ill Cancer Haematological Patients
1. To identify prognostic factors of short and medium term mortality, by underlining the
respective weights of organ dysfunction and characteristics of underlined malignancy
2. Evaluate the health related quality of life of intensive care survivors(SF36)
3. Impact of intensive care on families burden (HADS, IES).
4. Assess clinicians' satisfaction ( intensivists, haematologists and intensive care
nurses) in relation to medical decision-making.
5. Establish the relevance of antifungal treatments.
Observational Model: Cohort, Time Perspective: Prospective
Survival status at one year
survival status (alive or death) at one year
Elie Azoulay, MD, PhD
Saint-Louis Hospital, Paris, France
France: Ministry of Health